Abstract
Teradyne will report its quarterly results on April 28, 2026, Post Market; this preview distills consensus forecasts for revenue, profitability, and EPS alongside recent business developments and analyst views to frame what matters most for the upcoming print.
Market Forecast
Consensus for the upcoming quarter points to a sharp acceleration: revenue is projected at 1.21 billion US dollars, up 77.79% year over year; EBIT is estimated at 393.19 million US dollars, up 238.01% year over year; and EPS is expected to be 2.10, up 239.43% year over year. Forecasts for gross margin and net margin were not provided, so investors will focus on the operating leverage implied by the outsized yoy increases in EBIT and EPS relative to revenue.
The company’s core systems are poised to lead this step-up in performance, with attention on high-compute device test demand and faster design-to-test cycles. Within the portfolio, the most promising vector is the set of advanced semiconductor test solutions tied to AI and silicon-photonics–driven datacenter devices, where the consolidated revenue is projected to grow 77.79% year over year and the incremental dollars are expected to concentrate in the core test businesses.
Last Quarter Review
In the prior quarter, Teradyne delivered revenue of 1.08 billion US dollars (+43.89% year over year), a gross profit margin of 57.20%, GAAP net profit attributable to shareholders of 257.00 million US dollars (net profit margin 23.74%), and adjusted EPS of 1.80 (+89.47% year over year). Net profit increased 115.14% quarter over quarter, highlighting strong operating leverage and a favorable product mix against growing test intensity.
On the business mix, core systems anchored the performance: based on the last quarter’s revenue, approximately 79.11% came from Semiconductor Test (about 0.86 billion US dollars), 11.22% from Product Test (about 121.57 million US dollars), and 9.66% from Industrial Automation (about 104.74 million US dollars). The company’s consolidated top line grew 43.89% year over year in the period, with the performance led by high-value test platforms aligned to advanced compute and memory devices.
Current Quarter Outlook (with major analytical insights)
Main business: Core test platforms and consolidated profitability trajectory
The headline setup for the quarter centers on a revenue inflection to 1.21 billion US dollars (+77.79% year over year) with EBIT of 393.19 million US dollars (+238.01% year over year) and EPS of 2.10 (+239.43% year over year). The gap between revenue growth and EBIT/EPS growth implies a pronounced operating leverage effect, which typically arises from a higher absorption of fixed R&D and SG&A across a larger revenue base and a richer mix of high-throughput systems. Given the prior quarter’s 57.20% gross margin and 23.74% net margin, investors will parse whether mix and volume can keep margins stable-to-higher despite any incremental ramp costs.
In practical terms, the magnitude of the forecasted growth suggests a concentration of shipments toward systems that test complex AI and high-bandwidth components. Such platforms tend to carry strong gross margins, and as volume scales, factory loading can improve cost per unit. The faster cadence of design-to-test handoff also reduces non-recurring engineering intensity for each program as tools and methodologies are reused, allowing more of the incremental revenue to fall through to operating profit.
Management’s ongoing push to compress development and debug cycles is a second profitability lever this quarter. The acquisition of TestInsight augments the company’s software toolkit—from pattern conversion and validation through virtual test—so test programs can be ready earlier in the silicon cycle. That is crucial for complex AI chips where time-to-qualify is a gating factor. If these tools accelerate customer program starts and shorten time to revenue, the company can recognize higher software and services attachment and unlock incremental utilization on installed testers. Together, scale, mix, and software leverage underpin the steep forecasted step-up in EBIT and EPS relative to revenue.
Most promising business vector: Advanced semiconductor test tied to AI, memory, and silicon photonics
The most compelling growth vector inside the portfolio is advanced semiconductor test applications connected to AI compute, high-speed memory, and the emergence of silicon photonics in datacenter interconnect. In the last quarter’s revenue mix, Semiconductor Test accounted for roughly 79.11% (about 0.86 billion US dollars), illustrating the scale at which core test products already contribute. With consolidated revenue expected to climb 77.79% year over year this quarter, the incremental growth dollars are set to concentrate here, supported by more complex device architectures and higher test intensity per device.
Two recent business moves reinforce this theme. First, the launch of the Photon 100 opto-electric automated test platform targets high-volume silicon photonics and co-packaged optics, enabling high-throughput test from wafer to module. This aligns the company with the shift toward optical connectivity in advanced servers and networking gear, where reliability requirements and module complexity increase the breadth and depth of test. Expanding into this area deepens the testable content per system and broadens the addressable set of devices that require rigorous screening at scale.
Second, the integration of TestInsight’s design-to-test software is expected to reduce customers’ debug cycles and improve test coverage for complex AI chips. By initiating test program readiness earlier and closing validation gaps in virtual environments, customers can ramp to volume faster. That capability not only enhances the value proposition of the hardware platforms but also increases the likelihood of software and services attachment, which can support margin resilience. Together, these developments point to a sustained uplift in both unit volumes and monetization per project in advanced semiconductor test.
Key share price drivers this quarter: Order momentum, margin mix, and execution signals
Order momentum and backlog conversion will be a critical signal. The forecasted 77.79% year-over-year revenue growth implies strong bookings in prior months; the composition of those orders—particularly the balance between high-compute device test and other categories—will influence gross margin trajectory and the sustainability of run-rate revenue. Investors will watch for commentary on shipment linearity through the quarter and any early indications of visibility into the next cycle of ramps from lead AI and memory programs.
Mix and incremental margins are the second driver. The prior quarter’s gross margin of 57.20% sets a reference point, but the substantial step-up in volume can lift or compress margins depending on training and launch costs, service attach rates, and the scope of new platform deployments. If a higher proportion of complex test platforms and software attachments dominates the shipments, gross and operating margins should benefit; conversely, a heavier contribution from earlier-stage ramps or unusually large configurations with higher setup costs could temporarily temper margin expansion despite strong revenue growth. The magnitude of the EBIT forecast suggests efficiency tailwinds, but commentary on factory utilization and cost normalization will be pivotal to the stock’s reaction.
Execution within adjacent growth initiatives rounds out the picture. In robotics, the company signaled assertive IP protection, securing a preliminary injunction in Germany related to software infringement affecting the Universal Robots franchise. While this legal development does not directly frame near-term test revenue, it underscores management’s focus on safeguarding software differentiation in automation. In communications test, the LitePoint unit’s collaboration to advance next-generation 5G millimeter-wave open radio units supports a pipeline of systems and software that can add incremental demand over time. These adjacent moves, combined with the Photon 100 launch and TestInsight integration, are evidence of a broader strategy to expand testable content and compress customer time-to-ramp, both of which can reinforce multi-quarter revenue durability if execution remains on track.
Analyst Opinions
Across the recent period, the ratio of bullish to neutral/bearish opinions trends positive, with multiple large brokerages reiterating or raising favorable views versus a smaller number of downgrades and holds. The majority stance is bullish, reflected in reiterated Buy/Outperform ratings and rising price targets keyed to accelerating demand for advanced test platforms.
TD Cowen has reiterated its Buy view, with analyst Krish Sankar citing the uplift from AI-driven test demand and an expanding automated test market; recent commentary included a price target of 325 US dollars. The rationale emphasizes rising test intensity for complex AI devices and strengthens the case that higher-compute ramps should sustain above-trend growth for core systems. The bullish view also underscores software leverage and the stickiness of design-to-test workflows that can accelerate customer ramps—consistent with the integration of new software capabilities and the company’s ambition to streamline program launch cycles.
Susquehanna’s positive stance, alongside a price target uplift to 415 US dollars during the period, aligns with the idea that elevated high-performance compute programs will elongate the demand cycle for advanced test. The firm’s view interprets the current revenue inflection—77.79% year-over-year growth in the upcoming quarter—as a sign that bookings are converting broadly and that the profit algorithm is benefiting from scale and mix. That aligns with the step-change in EBIT (+238.01% year over year) and EPS (+239.43% year over year) implied by the forecasts, suggesting a favorable operating leverage setup in the near term.
Baird maintained an Outperform rating and lifted its price target to 332 US dollars, reinforcing the majority’s constructive tone. The firm highlights the durability of demand in advanced device test as customers normalize higher test coverage and throughput standards across successive silicon cycles. In practical terms, that means more systems per program and deeper software utilization, both of which can support margins as volume expands. The Photon 100 introduction and the acquisition of TestInsight are consistent with this narrative: each broadens the testable landscape or compresses time-to-market for customers, improving the probability that orders remain robust and that deployments scale efficiently.
Cantor Fitzgerald also maintained a Buy rating with a 270 US dollar target during the period. While this target is more conservative than some peers, the positive stance supports the consensus that core test demand is accelerating. Analysts emphasize that the sharper year-over-year increases in EBIT and EPS versus revenue reflect a favorable mix and tighter cost control, both of which can generate upside to profitability if revenue lands near or above the 1.21 billion US dollars mark.
There were holds and a downgrade, which the majority view effectively absorbs. Northland Securities shifted to Hold with a 270 US dollar target in one update, and President Capital moved to Neutral while raising its target to 308 US dollars earlier in the year. KeyBanc also maintained a Hold. Even with these more cautious tones, the aggregate signal remains tilted toward Buy/Outperform, and the balance of commentary is that the outsized step-up in revenue and profits is grounded in visible program ramps and growing test intensity rather than a transient spike.
Taken together, the majority of analysts focus on three bullish anchors for this quarter. First, the scale of the revenue acceleration, supported by prior bookings, suggests that backlog conversion is healthy and that shipment momentum is broadening across complex device categories. Second, forecasted EBIT and EPS growth far ahead of revenue imply that the business is now realizing stronger operating leverage and a richer mix of higher-value systems and software, with a margin structure that can remain resilient. Third, new product and software moves—the Photon 100 launch and the TestInsight acquisition—should shorten customer debug cycles and expand testable content in emerging areas like silicon photonics, creating additional vectors for sustained growth. If reported results and management’s commentary corroborate these points on April 28, 2026, Post Market, the majority view anticipates the stock will respond favorably to confirmation of the revenue step-up and leverage dynamics already embedded in consensus expectations.Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments